$1.14/ day, billed weekly
Cancel anytime

(Ad-Free, Unlimited access)

NO CREDIT CARD REQUIRED

RDGT

Ridgetech, Inc. (RDGT)

$1.02

Delayed price

PASS

BUY Advisory
SELL Advisory (Profit)
SELL Advisory (Loss)

Profit
Loss
Pass (Skip investing)

Time period over

ALL
YEAR
MONTH
WEEK

Upturn Advisory Summary

04/22/2025: RDGT (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock

Historic Profit -18.72%

Avg. Invested days 40

Today’s Advisory PASS

Upturn Star Rating

Upturn Advisory Performance

2.0

Stock Returns Performance

1.0

Profits based on simulation

Last Close 04/22/2025

Key Highlights

Company Size ETF	Market Capitalization 0 USD	Price to earnings Ratio -	1Y Target Price -
Price to earnings Ratio -	1Y Target Price -
Volume (30-day avg) 87375	Beta -	52 Weeks Range 0.72 - 3.08	Updated Date 04/15/2025
52 Weeks Range 0.72 - 3.08	Updated Date 04/15/2025
Dividends yield (FY) -	Basic EPS (TTM) -

Earnings Date

Report Date -

When -

Estimate -

Actual -

Profitability

Profit Margin -

Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -

Return on Equity (TTM) -

Valuation

Trailing PE -	Forward PE -	Enterprise Value -	Price to Sales(TTM) -
Enterprise Value -	Price to Sales(TTM) -
Enterprise Value to Revenue -	Enterprise Value to EBITDA -	Shares Outstanding -	Shares Floating -
Shares Outstanding -	Shares Floating -
Percent Insiders -	Percent Institutions -

Analyst Ratings

Rating -	Target Price -	Buy -	Strong Buy -
Buy -	Strong Buy -
Hold -	Sell -	Strong Sell -
Strong Sell -

About Ridgetech, Inc.

Exchange NASDAQ	Headquaters -
IPO Launch date 2008-05-16	Chairman & CEO Mr. Lei Liu M.D.
Sector Healthcare	Industry Pharmaceutical Retailers	Full time employees 939	Website https://www.jiuzhou360.com
Full time employees 939	Website https://www.jiuzhou360.com

Ridgetech, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours. In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing. Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms. Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates pharmacies under the Jiuzhou Grand Pharmacy name. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, the People's Republic of China.

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.